Respiratory Agents

Respiratory Agents

Respiratory agents, tailored for disorders of the respiratory system, play a pivotal role in restoring respiratory function. Conditions like asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis highlight the importance of these medications in providing relief and promoting respiratory health.

These agents take centre stage in addressing respiratory challenges. Medications for asthma, such as bronchodilators and inhaled corticosteroids, work to alleviate airway constriction and inflammation. For COPD, medications aim to improve airflow and manage symptoms, contributing to enhanced respiratory well-being.

Did you know?
The spiral design of many dry powder inhalers (DPIs) isn't just for aesthetics. This intricate pattern helps break up and disperse the powdered medication more effectively, ensuring a consistent and precise dose with each inhalation.

  • Pharmgenity Health Ambroxol HCL
  • Pharmgenity Health Levosalbutamol Sulphate
  • Pharmgenity Health Terbutaline Sulphate
  • Pharmgenity Health Acebrophylline
Other products are available based on customer requirements

Frequently Asked Questions

Ambroxol HCL is a classic mucolytic that works by increasing serous bronchial secretion and reducing mucus viscosity, making it easier to clear phlegm from the respiratory tract. Acebrophylline combines mucolytic and bronchodilator properties — it not only thins mucus but also relaxes bronchial smooth muscles, making it more suitable for patients who need both airway clearance and bronchodilation, such as those with asthma complicated by excessive mucus production.

Levosalbutamol Sulphate is the R-enantiomer of salbutamol and offers higher receptor affinity for beta-2 adrenergic receptors in the lungs, making it particularly effective for acute asthma attacks with fewer cardiovascular side effects. Terbutaline Sulphate is another selective beta-2 agonist commonly used for both acute relief and maintenance therapy in COPD and asthma. Levosalbutamol is generally preferred when minimizing cardiac stimulation is crucial, while Terbutaline is often chosen for its longer duration of action in chronic management.

Yes, our respiratory APIs can be supplied with particle size specifications suitable for inhalation-grade formulations. We understand that respiratory products intended for inhalers and nebulizers require strict control over particle size distribution, typically in the respirable range of 1-5 microns. We work closely with customers to define the specific particle size, crystalline form, and purity profile needed for their dry powder inhalers, metered-dose inhalers, or nebulizer solutions.

Absolutely. We can supply individual respiratory APIs that are commonly combined in fixed-dose combination inhalers. For example, Levosalbutamol Sulphate and Terbutaline Sulphate can be paired with inhaled corticosteroids in combination therapies for asthma and COPD management. We coordinate the supply chain to ensure consistent quality across all components of your combination product and provide the necessary regulatory documentation for each API.

Our respiratory APIs are manufactured in WHO-GMP certified facilities and comply with USP, BP, IP, and EP pharmacopeial standards. Each batch is tested for assay potency, related substances, residual solvents, heavy metals, microbial limits, and specific optical rotation where applicable. We provide complete documentation packages including certificates of analysis, stability data, impurity profiles, and regulatory dossiers for international registrations in regulated and emerging markets alike.